141 related articles for article (PubMed ID: 31345950)
1. Suppression of Prostate Cancer Pathogenesis Using an MDA-9/Syntenin (SDCBP) PDZ1 Small-Molecule Inhibitor.
Das SK; Kegelman TP; Pradhan AK; Shen XN; Bhoopathi P; Talukdar S; Maji S; Sarkar D; Emdad L; Fisher PB
Mol Cancer Ther; 2019 Nov; 18(11):1997-2007. PubMed ID: 31345950
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological inhibition of MDA-9/Syntenin blocks breast cancer metastasis through suppression of IL-1β.
Pradhan AK; Maji S; Bhoopathi P; Talukdar S; Mannangatti P; Guo C; Wang XY; Cartagena LC; Idowu M; Landry JW; Sarkar D; Emdad L; Cavenee WK; Das SK; Fisher PB
Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34016751
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin.
Kegelman TP; Wu B; Das SK; Talukdar S; Beckta JM; Hu B; Emdad L; Valerie K; Sarkar D; Furnari FB; Cavenee WK; Wei J; Purves A; De SK; Pellecchia M; Fisher PB
Proc Natl Acad Sci U S A; 2017 Jan; 114(2):370-375. PubMed ID: 28011764
[TBL] [Abstract][Full Text] [Related]
4. Knockout of MDA-9/Syntenin (SDCBP) expression in the microenvironment dampens tumor-supporting inflammation and inhibits melanoma metastasis.
Das SK; Guo C; Pradhan AK; Bhoopathi P; Talukdar S; Shen XN; Emdad L; Subler MA; Windle JJ; Sarkar D; Wang XY; Fisher PB
Oncotarget; 2016 Jul; 7(30):46848-46861. PubMed ID: 27341128
[TBL] [Abstract][Full Text] [Related]
5. Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis.
Pradhan AK; Modi J; Maji S; Kumar A; Bhoopathi P; Mannangatti P; Guo C; Afosah DK; Mochel MC; Mukhopadhyay ND; Kirkwood JM; Wang XY; Desai UR; Sarkar D; Emdad L; Das SK; Fisher PB
Mol Cancer Ther; 2023 Oct; 22(10):1115-1127. PubMed ID: 37721536
[TBL] [Abstract][Full Text] [Related]
6. The MDA-9/Syntenin/IGF1R/STAT3 Axis Directs Prostate Cancer Invasion.
Das SK; Pradhan AK; Bhoopathi P; Talukdar S; Shen XN; Sarkar D; Emdad L; Fisher PB
Cancer Res; 2018 Jun; 78(11):2852-2863. PubMed ID: 29572229
[TBL] [Abstract][Full Text] [Related]
7. Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression.
Gangemi R; Mirisola V; Barisione G; Fabbi M; Brizzolara A; Lanza F; Mosci C; Salvi S; Gualco M; Truini M; Angelini G; Boccardo S; Cilli M; Airoldi I; Queirolo P; Jager MJ; Daga A; Pfeffer U; Ferrini S
PLoS One; 2012; 7(1):e29989. PubMed ID: 22267972
[TBL] [Abstract][Full Text] [Related]
8. MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer.
Menezes ME; Shen XN; Das SK; Emdad L; Sarkar D; Fisher PB
Oncotarget; 2016 Dec; 7(49):80175-80189. PubMed ID: 27863394
[TBL] [Abstract][Full Text] [Related]
9. MDA-9/syntenin is essential for factor VIIa-induced signaling, migration, and metastasis in melanoma cells.
Aissaoui H; Prévost C; Boucharaba A; Sanhadji K; Bordet JC; Négrier C; Boukerche H
J Biol Chem; 2015 Feb; 290(6):3333-48. PubMed ID: 25505176
[TBL] [Abstract][Full Text] [Related]
10. MDA-9/syntenin is a key regulator of glioma pathogenesis.
Kegelman TP; Das SK; Hu B; Bacolod MD; Fuller CE; Menezes ME; Emdad L; Dasgupta S; Baldwin AS; Bruce JN; Dent P; Pellecchia M; Sarkar D; Fisher PB
Neuro Oncol; 2014 Jan; 16(1):50-61. PubMed ID: 24305713
[TBL] [Abstract][Full Text] [Related]
11. Regulation of protective autophagy in anoikis-resistant glioma stem cells by SDCBP/MDA-9/Syntenin.
Talukdar S; Pradhan AK; Bhoopathi P; Shen XN; August LA; Windle JJ; Sarkar D; Furnari FB; Cavenee WK; Das SK; Emdad L; Fisher PB
Autophagy; 2018; 14(10):1845-1846. PubMed ID: 30118375
[TBL] [Abstract][Full Text] [Related]
12. MDA-9/Syntenin-Slug transcriptional complex promote epithelial-mesenchymal transition and invasion/metastasis in lung adenocarcinoma.
Wang LK; Pan SH; Chang YL; Hung PF; Kao SH; Wang WL; Lin CW; Yang SC; Liang CH; Wu CT; Hsiao TH; Hong TM; Yang PC
Oncotarget; 2016 Jan; 7(1):386-401. PubMed ID: 26561205
[TBL] [Abstract][Full Text] [Related]
13. mda-9/Syntenin promotes metastasis in human melanoma cells by activating c-Src.
Boukerche H; Su ZZ; Prévot C; Sarkar D; Fisher PB
Proc Natl Acad Sci U S A; 2008 Oct; 105(41):15914-9. PubMed ID: 18832467
[TBL] [Abstract][Full Text] [Related]
14. MDA-9/Syntenin/SDCBP: new insights into a unique multifunctional scaffold protein.
Pradhan AK; Maji S; Das SK; Emdad L; Sarkar D; Fisher PB
Cancer Metastasis Rev; 2020 Sep; 39(3):769-781. PubMed ID: 32410111
[TBL] [Abstract][Full Text] [Related]
15. MDA-9/syntenin interacts with ubiquitin via a novel ubiquitin-binding motif.
Okumura F; Yoshida K; Liang F; Hatakeyama S
Mol Cell Biochem; 2011 Jun; 352(1-2):163-72. PubMed ID: 21359963
[TBL] [Abstract][Full Text] [Related]
16. Targeting tumor invasion: the roles of MDA-9/Syntenin.
Kegelman TP; Das SK; Emdad L; Hu B; Menezes ME; Bhoopathi P; Wang XY; Pellecchia M; Sarkar D; Fisher PB
Expert Opin Ther Targets; 2015 Jan; 19(1):97-112. PubMed ID: 25219541
[TBL] [Abstract][Full Text] [Related]
17. Fragment-based drug design targeting syntenin PDZ2 domain involved in exosomal release and tumour spread.
Garcia M; Hoffer L; Leblanc R; Benmansour F; Feracci M; Derviaux C; Egea-Jimenez AL; Roche P; Zimmermann P; Morelli X; Barral K
Eur J Med Chem; 2021 Nov; 223():113601. PubMed ID: 34153575
[TBL] [Abstract][Full Text] [Related]
18. Activation of the integrin effector kinase focal adhesion kinase in cancer cells is regulated by crosstalk between protein kinase Calpha and the PDZ adapter protein mda-9/Syntenin.
Hwangbo C; Kim J; Lee JJ; Lee JH
Cancer Res; 2010 Feb; 70(4):1645-55. PubMed ID: 20145126
[TBL] [Abstract][Full Text] [Related]
19. mda-9/Syntenin regulates the metastatic phenotype in human melanoma cells by activating nuclear factor-kappaB.
Boukerche H; Su ZZ; Emdad L; Sarkar D; Fisher PB
Cancer Res; 2007 Feb; 67(4):1812-22. PubMed ID: 17308124
[TBL] [Abstract][Full Text] [Related]
20. MDA-9/Syntenin: An emerging global molecular target regulating cancer invasion and metastasis.
Das SK; Sarkar D; Emdad L; Fisher PB
Adv Cancer Res; 2019; 144():137-191. PubMed ID: 31349898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
